Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I SAD/MAD Study of ETD-001 Gel in Healthy Chinese Subjects
NCT07674862Phase 1Completed
- Sponsor
- ETERN Therapeutics
- Start
- Mar 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing ETD-001 gel with PLACEBO (2 arms). Primary endpoint: Safety and Tolerability at Day 21. Started Mar 2026; status: completed.
02
Drugs
ETD-001
Beyond the preview
Go deeper on NCT07674862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674862.